07:00 , Aug 27, 2012 |  BC Week In Review  |  Clinical News

Bonalon Jelly regulatory update

Teijin said Japan's Ministry of Health, Labor and Welfare (MHLW) approved Bonalon Jelly, an oral jelly formulation of alendronate sodium hydrate, to treat osteoporosis. Teijin said it will likely launch the once-weekly product in December...